WCA
IDXX icon

Waratah Capital Advisors’s Idexx Laboratories IDXX Stock Holding History

Waratah Capital Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.57M Buy
12,474
+11,756
+1,637% +$6.59M 0.22% 88
2026
Q1 		$403K Sell
718
-316
-31% -$203K 0.02% 123
2025
Q4 		$700K Hold
1,034
– – 0.02% 137
2025
Q3 		$661K Sell
1,034
-26,675
-96% -$16.2M 0.01% 166
2025
Q2 		$14.9M Sell
27,709
-95,684
-78% -$45.8M 0.4% 53
2025
Q1 		$51.8M Buy
+123,393
New +$53.6M 1.39% 13
2023
Q4 		– Sell
-752
Closed -$329K – 174
2023
Q3 		$329K Sell
752
-18,867
-96% -$9.41M ﹤0.01% 148
2023
Q2 		$9.85M Buy
+19,619
New +$9.4M 0.19% 57
2023
Q1 		– Sell
-5,923
Closed -$2.42M – 195
2022
Q4 		$2.42M Buy
5,923
+4,150
+234% +$1.61M 0.04% 104
2022
Q3 		$578K Sell
1,773
-9,844
-85% -$3.62M 0.01% 158
2022
Q2 		$4.07M Buy
+11,617
New +$4.74M 0.09% 103
2022
Q1 		– Sell
-6,793
Closed -$4.47M – 214
2021
Q4 		$4.47M Buy
6,793
+1,038
+18% +$652K 0.08% 104
2021
Q3 		$3.58M Sell
5,755
-4,873
-46% -$3.27M 0.05% 112
2021
Q2 		$6.71M Buy
+10,628
New +$5.87M 0.09% 89
2020
Q1 		– Sell
-1,446
Closed -$378K – 125
2019
Q4 		$378K Sell
1,446
-3,995
-73% -$1.05M 0.04% 122
2019
Q3 		$1.48M Sell
5,441
-9,761
-64% -$2.72M 0.17% 95
2019
Q2 		$4.19M Sell
15,202
-1,138
-7% -$280K 0.47% 45
2019
Q1 		$3.65M Buy
+16,340
New +$3.37M 0.39% 54
2018
Q4 		– Sell
-8,190
Closed -$2.04M – 124
2018
Q3 		$2.04M Sell
8,190
-15,861
-66% -$3.85M 0.21% 84
2018
Q2 		$5.24M Sell
24,051
-16,146
-40% -$3.33M 0.58% 48
2018
Q1 		$7.69M Buy
+40,197
New +$7.42M 0.81% 39

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Waratah Capital Advisors's IDXX Position: Q2 2026 in Review

Waratah Capital Advisors increased its Idexx Laboratories (IDXX) stake by 1,637% in Q2 2026, buying an estimated $6.59M and bringing the position to 12,474 shares worth $6.57M. The position accounts for 0.22% of the portfolio, ranked #88.

Waratah Capital Advisors first reported a position in IDXX in Q1 2018 and has held it in 21 quarters since. The position peaked at $51.8M in Q1 2025. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Waratah Capital Advisors held 12,474 shares of Idexx Laboratories worth $6.57M as of Q2 2026.
  • Waratah Capital Advisors bought 11,756 Idexx Laboratories shares in Q2 2026, an estimated $6.59M.
  • Idexx Laboratories made up 0.22% of Waratah Capital Advisors's portfolio in Q2 2026, its #88 holding.
  • Waratah Capital Advisors first reported a position in Idexx Laboratories in Q1 2018 and has held it in 21 quarters since.
  • Waratah Capital Advisors's Idexx Laboratories position peaked at $51.8M in Q1 2025.
  • 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Waratah Capital Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.